Systematic review of rosacea treatments

Journal of the American Academy of Dermatology

Volumn 56, Issue 1, 2007, Pages 107-115

  van Zuuren, Esther J ^a   Gupta, Aditya K ^b,c   Gover, Melissa D ^c   Graber, Mark ^d   Hollis, Sally ^e  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c MEDIPROBE RESEARCH INC   (Canada)

^d UNIVERSITY OF IOWA   (United States)

^e LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZELAIC ACID; BENZOYL PEROXIDE; CLINDAMYCIN; CLONIDINE; ERYTHROMYCIN; FUSIDIC ACID; HYDROCORTISONE; ISOTRETINOIN; METRONIDAZOLE; OXYTETRACYCLINE; PERMETHRIN; PLACEBO; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; RETINOIC ACID; RILMENIDINE; SULFACETAMIDE; SULFUR; SUNSCREEN; TACROLIMUS; TETRACYCLINE;

APPLICATION SITE REACTION; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; CREAM; DATA ANALYSIS; DATA BASE; DERMATITIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRY EYE; DRY SKIN; ERYTHEMA; FETUS DISEASE; FLUSHING; GEL; HUMAN; LOTION; LOW DRUG DOSE; META ANALYSIS; MUCOSAL DRYNESS; MUTAGENICITY; MYALGIA; NEUROPATHY; OUTCOME ASSESSMENT; PAPULE; PRIORITY JOURNAL; PRURITUS; PUSTULE; REVIEW; ROSACEA; SIDE EFFECT; SKIN BURNING SENSATION; SKIN DEFECT; SKIN IRRITATION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; BENZOYL PEROXIDE; COSMETICS; DICARBOXYLIC ACIDS; DIET; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; HUMANS; METRONIDAZOLE; OMEPRAZOLE; PERMETHRIN; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; ROSACEA; SINGLE-BLIND METHOD; SUNSCREENING AGENTS; TETRACYCLINES; TREATMENT OUTCOME;

EID: 33845689517     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.04.084     Document Type: Review

References (93)

1. van Zuuren E.J., Graber M.A., Hollis S., Chaudhry M., Gupta A.K., and Gover M. Interventions for rosacea. The Cochrane Database of Systematic Reviews (2005). http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003262/frame.html . Accessed July 20, 2005
2. Crawford G.H., Pelle M.T., and James W.D. Rosacea, I: etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 51 (2004) 327-341
3. Wilkin J., Dahl M., Detmar M., Drake L., Feinstein A., Odom R., et al. Standard classification of rosacea: report of the National Rosacea Society expert committee on the classification and staging of rosacea. J Am Acad Dermatol 46 (2002) 584-587
4. Wilkin J., Dahl M., Detmar M., Drake L., Liang M.H., Odom R., et al. Standard grading system for rosacea: report of the National Rosacea Society expert committee on the classification and staging of rosacea. J Am Acad Dermatol 50 (2004) 907-912
5. Michel J.L., and Cabibel F. Frequency, severity and treatment of ocular rosacea during cutaneous rosacea. [French]. Ann Dermatol Venereol 130 (2003) 20-24
6. Berg M., and Liden S. An epidemiological study of rosacea. Acta Derm Venereol 69 (1989) 419-423
7. Jansen T., and Plewig G. Rosacea: classification and treatment. J R Soc Med 90 (1997) 144-150
8. Kligman A.M. A personal critique on the state of knowledge of rosacea. Dermatology 208 (2004) 191-197
9. Landow K. Unraveling the mystery of rosacea: keys to getting the red out. Postgrad Med 112 (2002) 51-58 82
10. Bikowski J.B., and Goldman M.P. Rosacea: where are we now?. J Drugs Dermatol 3 (2004) 251-261
11. Del Rosso J.Q. The use of topical azelaic acid 15% gel or metronidazole 0.75% gel for the treatment of rosacea: evaluation of a single-site comparative trial subset. [abstract]. J Am Acad Dermatol 50 (2004) P174
12. Ertl G.A., Levine N., and Kligman A.M. A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea. Arch Dermatol 130 (1994) 319-324
13. Espagne E., Guillaume J.C., Archimbaud A., Baspeyras M., Boitier F., Bussière M., et al. Double-blind study versus excipient of 0.75% metronidazole gel in the treatment of rosacea. [French]. Ann Dermatol Venereol 120 (1993) 129-133
14. Odom R.B. The subtypes of rosacea: implications for treatment. Cutis 73 (2004) 9-14
15. Powell F.C. The histopathology of rosacea: 'where's the beef?'. Dermatology 209 (2004) 173-174
16. Rebora A. Rosacea. J Invest Dermatol 88 Suppl (1987) 56s-60s
17. Shalita A., and Leyden J. Mechanism-based selection of pharmacologic agents for rosacea. Cutis 73 (2004) 15-18
18. Signore R.J. A pilot study of 5 percent permethrin cream versus 0.75 percent metronidazole gel in acne rosacea. Cutis 56 (1995) 177-179
19. Wilkin J.K., and DeWitt S. Treatment of rosacea: topical clindamycin versus oral tetracycline. Int J Dermatol 32 (1993) 65-67
20. Wolf Jr. J.E. The role of topical metronidazole in the treatment of rosacea. Cutis 73 (2004) 19-28
21. Dahl M.V., Katz H.I., Krueger G.G., Millikan L.E., Odom R.B., Parker F., et al. Topical metronidazole maintains remissions of rosacea. Arch Dermatol 134 (1998) 679-683
22. Maddin S. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol 40 (1999) 961-965
23. Nielsen P.G. A double-blind study of 1% metronidazole cream versus systemic oxytetracycline therapy for rosacea. Br J Dermatol 109 (1983) 63-65
24. Pelle M.T., Crawford G.H., and James W.D. Rosacea, II: therapy. J Am Acad Dermatol 51 (2004) 499-512
25. Curtin F., Elbourne D., and Altman D.G. Meta-analysis combining parallel and cross-over clinical trials, II: binary outcomes. Stat Med 21 (2002) 2145-2159
26. Bamford J.T., Tilden R.L., Blankush J.L., and Gangeness D.E. Effect of treatment of Helicobacter pylori infection on rosacea. Arch Dermatol 135 (1999) 659-663
27. Barnhorst Jr. D.A., Foster J.A., Chern K.C., and Meisler D.M. The efficacy of topical metronidazole in the treatment of ocular rosacea. Ophthalmology 103 (1996) 1880-1883
28. Bartholomew R.S., Reid B.J., Cheesebrough M.J., MacDonald M., and Galloway N.R. Oxytetracycline in the treatment of ocular rosacea: a double-blind trial. Br J Ophthalmol 66 (1982) 386-388
29. Bitar A., Bourgouin J., Doré N., Dubuc R., Giroux J., Landry M., et al. A double-blind randomized study of metronidazole (Flagyl) 1% cream in the treatment of acne rosacea, a placebo controlled study. Drug Invest 2 (1990) 242-248
30. Bjerke J., Nyfors A., Austad J., and Rajka G. Metronidazole (Elyzol) 1% cream vs. placebo cream in the treatment of rosacea. Clin Trials J 26 (1989) 187-194
31. Bjerke R., Fyrand O., and Graupe K. Double-blind comparison of azelaic acid 20% cream and its vehicle in treatment of papulo-pustular rosacea. Acta Derm Venereol 79 (1999) 456-459
32. Bleicher P.A., Charles J.H., and Sober A.J. Topical metronidazole therapy for rosacea. Arch Dermatol 123 (1987) 609-614
33. Breneman D.L., Stewart D., Hevia O., Hino P.D., and Drake L.A. A double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1 percent cream to vehicle in patients with rosacea. Cutis 61 (1998) 44-47
34. Breneman D., Savin R., VandePol C., Vamvakias G., Levy S., and Leyden J. Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea. Int J Dermatol 43 (2004) 381-387
35. Carmichael A.J., Marks R., Graupe K.A., and Zaumseil R.P. Topical azelaic acid in the treatment of rosacea. J Dermatol Treat 4 Suppl (1993) S19-S22
36. Elewski B.E., Fleischer Jr. A.B., and Pariser D.M. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial. Arch Dermatol 139 (2003) 1444-1450
37. Grosshans E., Michel C., Arcade B., and Cribier B. Rilmenidine in rosacea: a double-blind study versus placebo. [French]. Ann Dermatol Venereol 124 (1997) 687-691
38. Jorizzo J.L., Lebwohl M., and Tobey R.E. The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: a double-blind clinical trial. J Am Acad Dermatol 39 (1998) 502-504
39. Koçak M., Yaǧli S., Vahapoǧlu G., and Ekşioǧlu M. Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea: a randomized double-blind placebo-controlled study. Dermatology 205 (2002) 265-270
40. Marks R., and Ellis J. Comparative effectiveness of tetracycline and ampicillin in rosacea: a controlled trial. Lancet 2 (1971) 1049-1052
41. Montes L.F., Cordero A.A., Kriner J., Loder J., and Flanagan A.D. Topical treatment of acne rosacea with benzoyl peroxide acetone gel. Cutis 32 (1983) 185-190
42. Nielsen P.G. Treatment of rosacea with 1% metronidazole cream: a double-blind study. Br J Dermatol 108 (1983) 327-332
43. Özturkcan S., Ermertcan A.T., Sahin M.T., and Afçar F.S. Efficiency of benzoyl peroxide-erythromycin gel in comparison with metronidazole gel in the treatment of acne rosacea. J Dermatol 31 (2004) 610-617
44. Pye R.J., and Burton J.L. Treatment of rosacea by metronidazole. Lancet 1 (1976) 1211-1212
45. Saihan E.M., and Burton J.L. A double-blind trial of metronidazole versus oxytetracycline therapy for rosacea. Br J Dermatol 102 (1980) 443-445
46. Sauder D., Miller R., Gratton D., Danby W., Griffiths C., and Phillips S. The treatment of rosacea: the safety and efficacy of sodium sulfacetamide 10% and sulfur 5% lotion (Novacet) is demonstrated in a double-blind study. J Dermatol Treat 8 (1997) 79-85
47. Sneddon I.B. A clinical trial of tetracycline in rosacea. Br J Dermatol 78 (1966) 649-652
48. Tan J.K., Girard C., Krol A., Murray H.E., Papp K.A., Poulin Y., et al. Randomized placebo-controlled trial of metronidazole 1% cream with sunscreen SPF 15 in treatment of rosacea. J Cutan Med Surg 6 (2002) 529-534
49. Thiboutot D., Thieroff-Ekerdt R., and Graupe K. Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies. J Am Acad Dermatol 48 (2003) 836-845
50. Veien N.K., Christiansen J.V., Hjorth N., and Schmidt H. Topical metronidazole in the treatment of rosacea. Cutis 38 (1986) 209-210
51. Leyden J.J., Thiboutot D., and Shalita A. Photographic review of results from a clinical study comparing benzoyl peroxide 5%/clindamycin 1% topical gel with vehicle in the treatment of rosacea. Cutis 73 (2004) 11-17
52. Aitken G. Acne rosacea: efficacy of a metronidazole cream. [French]. Presse Med 12 (1983) 1490-1491
53. Aizawa H., and Niimura M. Oral spironolactone therapy in male patients with rosacea. J Dermatol 19 (1992) 293-297
54. Aronson I.K., Rumsfield J.A., West D.P., Alexander J., Fischer J.H., and Paloucek F.P. Evaluation of topical metronidazole gel in acne rosacea. Drug Intell Clin Pharm 21 (1987) 346-351
55. Bernstein J.E., and Soltani K. Alcohol-induced rosacea flushing blocked by naloxone. Br J Dermatol 107 (1982) 59-61
56. Bjerke J.R. Rosacea: clinical features and treatment. [Norwegian]. Tidsskr Nor Laegeforen 109 (1989) 2295-2297
57. Blom I., and Hornmark A.M. Topical treatment with sulfur 10 per cent for rosacea. Acta Derm Venereol 64 (1984) 358-359
58. Bukvić-Mokos Z., Basta-Juzbašić A., and Barašić-Druško V. Treatment of Helicobacter pylori infection in the management rosacea. Acta Dermatovenerol Croat 6 (1998) 185-188
59. Cunliffe W.J., Dodman B., and Binner J.G. Clonidine and facial flushing in rosacea. Br Med J 1 (1977) 105
60. Dahl M.V., Jarratt M., Kaplan D., Tuley M.R., and Baker M.D. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea. J Am Acad Dermatol 45 (2001) 723-730
61. De Witt S., and Wilkin J. Double blind, parallel study of efficacy and safety of clindamycine lotion in the treatment of rosacea. Clin Pharmacol Ther 41 (1987) 176
62. Dreno B., Dubertret L., Naeyaert J., De La Brassine M., Marks R., Powell F., et al. Comparison of the clinical efficacy and safety of metronidazole 0.75% cream with metronidazole 0.75% gel in the treatment of rosacea. P373. J Eur Acad Dermatol Venereol 11 Suppl (1998) S272-S273
63. Erdogan F.G., Yurtsever P., Aksoy D., and Eskioglu F. Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea. Arch Dermatol 134 (1998) 884-885
64. Fernandez-Obregon A. Oral use of azithromycin for the treatment of acne rosacea. Arch Dermatol 140 (2004) 489-490
65. Frigerio G., Mazzoni P., and Ferrari V. Dimensions of the sample and power of the clinical experimentation in a study of antibiotic therapy. [Italian]. Boll Chim Farm 108 (1969) 506-514
66. Frucht-Pery J., Sagi E., Hemo I., and Ever-Hadani P. Efficacy of doxycycline and tetracycline in ocular rosacea. Am J Ophthalmol 116 (1993) 88-92
67. Go M.J., and Wuite J. Comparative study of triamcinolone acetonide and hydrocortisone 17-butyrate in rosacea with special regard to the rebound phenomenon. Dermatologica 152 (1976) 239-246
68. Goldsmith M.F. New topical therapy for acne rosacea offers conspicuous improvement, no systemic effects. JAMA 261 (1989) 2014-2015
69. Guillet B., Rostain E., Powell F., Gimenez Camarasa C., Dahan E., Piérard G., et al. Metronidazole 0.75% gel and lotion are both effective in the treatment of rosacea. J Eur Acad Dermatol Venereol 12 Suppl (1999) S145
70. Hofer T. Continuous 'microdose' isotretinoin in adult recalcitrant rosacea. Clin Exp Dermatol 29 (2004) 204-205
71. Irvine C, Kumar P, Marks R. Acne and related disorders-proceedings of an international symposium. London: Marks R, Plewig G, and Dunitz Ltd; 1988. pp. 301-5.
72. Koch R., and Wilbrand G. Dark sulfonated shale oil versus placebo in the systemic treatment of rosacea. J Eur Acad Dermatol Venereol 12 Suppl (1999) S143-S144
73. Lebwohl M., Medansky R., Russo C., and Plott R. The comparative efficacy of sodium sulfacetamide 10%/sulfur 5% (Sulfacet-R) lotion and metronidazole 0.75% (metrogel) in the treatment of rosacea. J Geriatr Dermatol 3 (1995) 183-185
74. Loo W., Ayyalaraju A., Chawla M., Finlay A., Coles E., and Marks R. Ivermectin cream in rosacea: comparison with metronidazole gel. [abstract]. Br J Dermatol 151 (2004) 61
75. Nasir M.A. Treatment of rosacea with tetracycline and metronidazole-a comparative study. J Pak Med Assoc 35 (1985) 148-149
76. Nielsen P.G. The relapse rate for rosacea after treatment with either oral tetracycline or metronidazole cream. Br J Dermatol 109 (1983) 122
77. Sanchez J., Somolino A., Webster G., and Bradshaw M. Combined effect of doxycycline hyclate 20 mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea. J Am Acad Dermatol 50 (2004) 48
78. Schachter D., Schachter R., Long B., Shiffman N., Lester R., Miller S., et al. Comparison of metronidazole 1% cream versus oral tetracycline in patients with rosacea. Drug Invest 3 (1991) 220-224
79. Seal D.V., Wright P., Ficker L., Hagan K., Troski M., and Menday P. Placebo controlled trial of fusidic acid gel and oxytetracycline for recurrent blepharitis and rosacea. Br J Ophthalmol 79 (1995) 42-45
80. Torresani C., Pavesi A., and Manara G.C. Clarithromycin versus doxycycline in the treatment of rosacea. Int J Dermatol 36 (1997) 942-946
81. Utaş S., and Ünver U. Treatment of rosacea with ketoconazole. J Eur Acad Dermatol Venereol 8 (1997) 69-70
82. Van Landuyt H., Joubert-Lequain I., Humbert P., Lucas A., Drobacheff C., Mercier M., et al. Treatment of rosacea: clonidine (0.075 mg per day) versus placebo (initial results). [French]. Ann Dermatol Venereol 124 (1997) 729
83. Veien N.K. Metronidazole cream for the local treatment of rosacea. [Danish]. Ugeskr Laeger 150 (1988) 381-382
84. Veraldi S., Scarabelli G., Rizzitelli G., and Caputo R. Treatment of rosacea fulminans with isotretinoin and topical aclometasone dipropionate. Eur J Dermatol 6 (1996) 94-96
85. Wilkin J.K. Effect of nadolol on flushing reactions in rosacea. J Am Acad Dermatol 20 (1989) 202-205
86. Monk B., Logan R., Cook J., White J., and Mason R. Topical metronidazole in the treatment of rosacea. J Dermatol Treat 2 (1991) 91-93
87. Verea Hernando M., Margusino Framiñán L., Seco Vilariño C., Feal Cortizas B., and Cuña Estévez B. Comparative study of topical erythromycin and topical metronidazole in the treatment of rosacea. [Spanish]. Farm Clin 9 (1992) 472-479
88. Altman D., Schulz K., Moher D., Egger M., Davidoff F., Elbourne D., et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134 (2001) 663-694
89. de Groot A. De behandeling of rosacea. [Treatment of rosacea]. Gebu 32 (1998) 101-105
90. Thiboutot D.M. Acne and rosacea: new and emerging therapies. Dermatol Clin 18 (2000) 63-71 viii
91. Wilkin J.K. Rosacea. Int J Dermatol 22 (1983) 393-400
92. Wilkin J.K. Rosacea: pathophysiology and treatment. Arch Dermatol 130 (1994) 359-362
93. Bikowski J.B. Subantimicrobial dose doxycycline for acne and rosacea. Skinmed 2 (2003) 234-245